Investment Summary

EQT Life Sciences Invests In Xeltis

On December 2, 2014, growth capital firm EQT Life Sciences invested in medical products company Xeltis

Investment Highlights
  • This is EQT Life Sciences’ 3rd transaction in the Medical Products sector.
  • This is EQT Life Sciences’ 4th transaction in the Netherlands.

Investment Summary

Date 2014-12-02
Target Xeltis
Sector Medical Products
Investor(s) EQT Life Sciences
Deal Type Growth Capital

Target

Xeltis

Eindhoven, Netherlands
Xeltis is a clinical-stage medical device company developing a new generation of pulmonary valves and vascular grafts according to the principles of endogenous tissue regeneration. Xeltis was founded in 2006 and is based in Eindhoven, Netherlands.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

EQT Life Sciences


Category Growth Capital Firm
Founded 1987
PE ASSETS 3.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.


DEAL STATS #
Overall 6 of 47
Sector: Medical Products M&A 3 of 14
Type: Growth Capital M&A Deals 1 of 5
Country: Netherlands M&A 4 of 10
Year: 2014 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-08 MedEye

Den Bosch, Netherlands

MedEye is developing and marketing the MedEye product, a revolutionary approach to prevent medication errors in hospitals and improve efficiency. MedEye is based in Den Bosch, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-13 Cardiac Dimensions

Offenbach, Germany

Cardiac Dimensions is a medical device company commercializing the Carillon Mitral Contour System. This implantable device is designed to treat heart failure patients suffering from a dysfunctional mitral valve. Cardiac Dimensions was founded in 2001 and is based in Offenbach, Germany.

Buy -